The Start-up Revolutionizing Cancer Treatments
Long before a lab leak/pangolin connoisseur/over-eager chiropterologist made mRNA vaccines famous, Jake Becraft and Tasuku Kitada were exploring ways in which mRNA technology could be applied to treating disease.
They founded Strand Therapeutics in 2017 with the hopes of creating mRNA-based therapies for cancer and autoimmune conditions, and they have shown some early success with their technology.
In a trial currently running in Australia, a therapy Strand developed has destroyed melanoma tumors in several patients who were otherwise untreatable with existing medicines.
